Drug Research
Cellular Origins, ScaleReady Partner to Improve Cell Therapy Manufacturing
Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), entered into a collaborative partnership...
Drug Research
Gene & cell therapy manufacturing specialist Ascend launches with over $130M of funding as expert teams merge
Ascend Gene & Cell Therapies, a specialist company innovating manufacturing processes to improve quality, potency, safety and cost enabling better reach for gene therapy...
Drug Research
nVentic report reveals fast-growing manufacturer inventories fail to prevent medicine shortages
nVentic, the inventory optimization specialist, has today launched its 2023 Big Pharma Inventory Benchmarking Report. The report, which analyses the published corporate reports of...
Articles
Preparing for the New Era: A Guide to Transitioning Clinical Trials to CTIS Regulation in the EU
As of January 31, 2022, the EU has implemented the Regulation 2014/536 on clinical trials for Medicinal Products (MPs) intended for human use. This...
News
Connected Drug Delivery Devices Boost Healthcare Efficiency
The market for connected drug delivery devices is anticipated to witness a growth rate of almost 23.4% every year from 2022 to 2030. The...
Drug Research
Advancement In Process Control With New PEACE Algorithm
Researchers have gone on to develop a physics-enhanced autocorrelation-based estimator (PEACE) machine learning algorithm that can go ahead with the extraction of the particle...
Drug Research
High demand: Vetter expands production capacities and services offered at its Austrian site
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), continues to drive the expansion of capacities and services for the provision of clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read